NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT
NeuroSense Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.77M | -2.11M | -3.03M | -2.99M | -3.29M | -2.9M | -3.48M | -2.99M | -3.38M | -3.32M | -3.59M | -3.26M | -1.65M | -880K | -951K | -2.11M |
Interest Income | n/a | n/a | 2.17M | n/a | 338K | 3.69M | 138K | 67K | 206K | 335K | 144K | 572K | n/a | n/a | 11K | n/a |
Pretax Income | -1.8M | -2.15M | -857K | -5.4M | -2.95M | 784K | -2.68M | -3.89M | -3.15M | -2.99M | -3.48M | -2.71M | -101K | -888K | -928K | -2.12M |
Net Income | -1.8M | -2.15M | -857K | -5.4M | -2.95M | 784K | -5.22M | -2.92M | -3.15M | -2.99M | -3.48M | -2.71M | -101K | -888K | -928K | -2.12M |
Selling & General & Admin | 685K | 946K | 1.46M | 1.11M | 1.33M | 1.27M | 1.57M | 1.54M | 1.83M | 1.61M | 1.72M | 1.97M | 1.6M | 361K | 453K | 92K |
Research & Development | 1.09M | 1.16M | 1.57M | 1.88M | 1.96M | 1.63M | 1.91M | 2.1M | 1.54M | 1.71M | 1.87M | 1.3M | 46K | 519K | 498K | 2.02M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.77M | 2.11M | 3.03M | 2.99M | 3.29M | 2.9M | 3.48M | 2.99M | 3.38M | 3.32M | 3.59M | 3.26M | 1.65M | 880K | 951K | 2.11M |
Interest Expense | n/a | 41K | n/a | 2.41M | 1K | 12K | 1.89M | 310K | n/a | 10K | 35K | 23K | n/a | n/a | n/a | 13K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.77M | 2.11M | 3.03M | 2.99M | 3.29M | 2.9M | 3.48M | 2.99M | 3.38M | 3.32M | 3.59M | 3.26M | 1.65M | 880K | 951K | 2.11M |
Income Tax Expense | n/a | n/a | n/a | -43.28K | n/a | n/a | -2.17M | -62K | n/a | n/a | n/a | n/a | n/a | -8.75K | n/a | -750 |
Shares Outstanding (Basic) | 21.65M | 19.81M | 18.05M | 15.4M | 15.38M | 13.62M | 13.62M | 11.79M | 11.78M | 11.59M | 11.6M | 11.31M | 10.94M | 10.77M | 10.94M | 5.58M |
Shares Outstanding (Diluted) | 21.65M | 19.81M | 18.05M | 15.4M | 15.38M | 13.62M | 13.62M | 11.79M | 11.78M | 11.59M | 11.6M | 11.31M | 10.94M | 10.77M | 10.94M | 5.58M |
EPS (Basic) | -0.09 | -0.11 | -0.05 | -0.35 | -0.19 | 0.06 | -0.38 | -0.25 | -0.25 | -0.23 | -0.3 | -0.24 | -0.01 | -0.08 | -0.08 | -0.19 |
EPS (Diluted) | -0.09 | -0.11 | -0.05 | -0.35 | -0.19 | 0.06 | -0.38 | -0.25 | -0.25 | -0.23 | -0.3 | -0.24 | -0.01 | -0.08 | -0.08 | -0.19 |
EBITDA | -1.77M | -2.11M | -3.03M | -2.99M | -5.15M | 796K | -5.53M | -2.99M | -3.15M | -2.98M | -3.45M | -2.69M | -1.65M | -879K | -940K | -2.11M |
EBIT | -1.77M | -2.11M | -3.03M | -2.99M | -5.15M | 2.99M | -5.53M | -2.99M | -3.15M | -2.98M | -3.45M | -2.69M | -1.65M | -888K | -940K | -2.11M |
Depreciation & Amortization | 5.5K | 5.25K | 5.5K | 5.25K | 5.25K | 3K | 23.5K | 3K | 3K | 750.00 | 20.5K | 750.00 | 750.00 | 750.00 | 750.00 | 750.00 |